Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01789840 · ClinicalTrials.gov registry record · NA
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
A NA study, sponsored by Merit Medical Systems.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT01789840 is a NA study that was terminated before completion, run by Merit Medical Systems. The registered enrollment target is 59 participants.
The verdict
NCT01789840, a NA study, was terminated before completion, sponsored by Merit Medical Systems.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) for prostatic artery embolization (PAE) using Embosphere Microspheres compared to conventional transurethral resection of the prostate (TURP).
Interventions
- DEVICE Embosphere Microspheres
- PROCEDURE TURP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01789840
The ClinicalTrials.gov registry entry for NCT01789840 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merit Medical Systems, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Embosphere Microspheres is the first listed.
NCT01789840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01789840 about?
NCT01789840 is a clinical study titled "Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia". The purpose of this study is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) for prostatic artery embolization (PAE) using Embosphere Microspheres compared to conventional transurethral resection of the prosta...
What is the current status of trial NCT01789840?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 2013-07. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01789840?
The interventions under investigation include: Embosphere Microspheres (DEVICE), TURP (PROCEDURE).
Who is sponsoring clinical trial NCT01789840?
This trial is sponsored by Merit Medical Systems, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.